<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04663568</url>
  </required_header>
  <id_info>
    <org_study_id>LNG_TS</org_study_id>
    <nct_id>NCT04663568</nct_id>
  </id_info>
  <brief_title>Levonorgestrel-releasing Intrauterine System and Tubal Ligation</brief_title>
  <official_title>Levonorgestrel-releasing Intrauterine System: A Emerging Tool for Conservative Treatment of Pain and Bleeding After Tubal Ligation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Today tubal sterilization is a simple, safe, and cost-effective method of achieving long-term&#xD;
      contraception. Sterilization is an ideal method of permanent contraception in developing&#xD;
      countries where access to health care providers is limited. The percentage of women who use&#xD;
      sterilization as a method of contraception rises from about 5% between 20 and 24 years of age&#xD;
      to almost 50% for those between 40 and 44 years of age. The most widely touted and most&#xD;
      significant health benefit of tubal sterilization appears to be a reduced risk of ovarian&#xD;
      cancer.&#xD;
&#xD;
      Post-tubal ligation syndrome includes pain during intercourse, aching lower back,&#xD;
      premenstrual tension syndrome, uterine hemorrhage, and absence of menstruation. The syndrome&#xD;
      is caused by blood circulation problems in and around the Fallopian tubes and ovaries,&#xD;
      pressure on nerves, and intrapelvic adhesion. Since the symptoms of this syndrome are mild,&#xD;
      simple symptomatic treatment is sufficient in most cases. In some cases, however,&#xD;
      hysterectomy may be necessary.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The level of pain from before to 6 months after levonorgestrel-releasing intrauterine system insertion</measure>
    <time_frame>6 months</time_frame>
    <description>It will be measured by visual analogue scale from 0 to 10</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Tubal Ligation</condition>
  <arm_group>
    <arm_group_label>Levonorgestrel-releasing intrauterine system</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Levonorgestrel-releasing intrauterine system</intervention_name>
    <description>Levonorgestrel-releasing intrauterine system will be inserted during the menstrual cycle</description>
    <arm_group_label>Levonorgestrel-releasing intrauterine system</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women aged from 30-40 year&#xD;
&#xD;
          -  Woman subjected to tubal ligation&#xD;
&#xD;
          -  Women 12 month postpartum&#xD;
&#xD;
          -  Non lactating women&#xD;
&#xD;
          -  Nomedical disorders&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  contraindication for Levonorgestrel-releasing Intrauterine System&#xD;
&#xD;
          -  Women with any uterine or ovarian pathology&#xD;
&#xD;
          -  women refuse to participate&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Women Health Hospital - Assiut university</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed K ALi, MD</last_name>
      <phone>+201005537951</phone>
      <email>m_khairy2001@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 5, 2020</study_first_submitted>
  <study_first_submitted_qc>December 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2020</study_first_posted>
  <last_update_submitted>December 5, 2020</last_update_submitted>
  <last_update_submitted_qc>December 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohammed Khairy Ali</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levonorgestrel</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

